Skip to main navigation Skip to search Skip to main content

Light-responsive nanomedicine for biophotonic imaging and targeted therapy

  • Jihwan Son
  • , Gawon Yi
  • , Jihye Yoo
  • , Changhee Park
  • , Heebeom Koo
  • , Hak Soo Choi
  • The Catholic University of Korea
  • Harvard University

Research output: Contribution to journal › Review article › peer-review

154 Scopus citations

Abstract

Nanoparticles (NPs) play a key role in nanomedicine in multimodal imaging, drug delivery and targeted therapy of human diseases. Consequently, due to the attractive properties of NPs including high stability, high payload, multifunctionality, design flexibility, and efficient delivery to target tissues, nanomedicine employs various types of NPs to enhance targeting and treatment efficacy. In this review, we primarily focus on light-responsive materials, such as fluorophores, photosensitizers, semiconducting polymers, carbon structures, gold particles, quantum dots, and upconversion crystals, for their biomedical applications. Armed with these nanomaterials, NPs represent a growing potential in biophotonic imaging (luminescence, photoacoustic, surface enhanced Raman scattering, and optical coherence tomography) as well as targeted therapy (photodynamic therapy, photothermal therapy, and light-responsive drug release).

Original languageEnglish
Pages (from-to)133-147
Number of pages15
JournalAdvanced Drug Delivery Reviews
Volume138
DOIs
StatePublished - 1 Jan 2019

Bibliographical note

Publisher Copyright:
© 2018 Elsevier B.V.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Light-responsiveness
  • Nanomedicine
  • Optical imaging
  • Targeted therapy

Fingerprint

Dive into the research topics of 'Light-responsive nanomedicine for biophotonic imaging and targeted therapy'. Together they form a unique fingerprint.

Cite this